This asthma action plan is specifically for patients using the combination medication Symbicort (budesonide and formoterol) as an anti-inflammatory reliever with or without maintenance.
Note: Symbicort is not recommended for use in Australia in children under 12 years.
Symbicort SMART Asthma Action Plan - Turbuhaler only
Symbicort SMART Asthma Action Plan - Rapihaler only
Symbicort SMART Asthma Action Plans in other languages
Note: This is a symptom-based asthma action plan.
